Hester Biosciences consolidated net profit rises 1138.76% in the March 2026 quarter
(15 May 2026)

Back
Net profit of Hester Biosciences rose 1138.76% to Rs 15.98 crore in the quarter ended March 2026 as against Rs 1.29 crore during the previous quarter ended March 2025. Sales rose 22.19% to Rs 100.11 crore in the quarter ended March 2026 as against Rs 81.93 crore during the previous quarter ended March 2025.

For the full year,net profit rose 102.40% to Rs 55.64 crore in the year ended March 2026 as against Rs 27.49 crore during the previous year ended March 2025. Sales rose 6.91% to Rs 332.60 crore in the year ended March 2026 as against Rs 311.10 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales100.1181.93 22 332.60311.10 7
OPM %34.2923.41 -26.0619.63 -
PBDT28.067.92 254 91.7856.37 63
PBT22.153.75 491 72.9039.57 84
NP15.981.29 1139 55.6427.49 102

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew